companiesCompany

Toray Industries

Toray Industries is the Japanese materials group, known for carbon fibre and synthetic fibres, whose pharmaceutical division created the antibody TRK-950 against CAPRIN-1, a protein found on many solid tumours.

Also called: Toray東レTSE:3402

Toray Industries is a Tokyo-based chemicals and materials company whose pharmaceutical business makes the pruritus drug nalfurafine and interferon-beta. TRK-950 is a humanised antibody against CAPRIN-1 (cytoplasmic activation/proliferation-associated protein 1), a cytoplasmic protein that Toray found on the surface of breast, ovarian, gastric and other cancer cells; it is in phase 1/2 trials alone and with chemotherapy and checkpoint inhibitors in solid tumours.

Headquarters

Tokyo, JP

Scorecard

All companies

#432of 1244 companies, score 8

phase 1/2 +1
targets +2
modalities +2
registry trials +3

0 approved, 0 in phase 3, 1 earlier, 1 targets, 2 registry studies. Formula on the scorecards page.

Type

Large pharma · TSE:3402

Stage

Public

Website

www.toray.com/

Founded

1926

Products

1top

Phase 2monoclonal antibody (per the sponsor's pipeline page; form not stated in the registry record)

TRK-950

TRK-950 is an experimental investigational agent whose form is not stated in the registry from Toray Industries in phase 2 trials for gastric & gastro-oesophageal junction cancer and melanoma, aimed at NTRK.